Search Results - "MALIN, J. L"

Evaluating the quality of cancer care : Development of cancer quality indicators for a global quality assessment tool by MALIN, J. L, ASCH, S. M, KERR, E. A, MCGLYNN, E. A

“…The rise of managed care has increased interest in measuring, reporting, and improving quality of care. To date, quality assessment has relied on a leading…”
Get full text

Validity of Cancer Registry Data for Measuring the Quality of Breast Cancer Care by Malin, Jennifer L., Kahn, Katherine L., Adams, John, Kwan, Lorna, Laouri, Marianne, Ganz, Patricia A.

“…Background: Various groups have called for a national system to monitor the quality of cancer care. The validity of cancer registry data for quality of cancer…”
Get full text

Tracking managed care: the importance of a cash incentive for medical director response to a survey by Malin, J L, Rideout, J, Ganz, P A

“…To assess the impact of a monetary incentive in a survey mailed to medical directors of large medical groups and independent practice associations (IPAs)…”
Get full text

Use of Colony-Stimulating Factors With Chemotherapy: Opportunities for Cost Savings and Improved Outcomes by Potosky, Arnold L., Malin, Jennifer L., Kim, Benjamin, Chrischilles, Elizabeth A., Makgoeng, Solomon B., Howlader, Nadia, Weeks, Jane C.

“…Myeloid colony-stimulating factors (CSFs) decrease the risk of febrile neutropenia (FN) from high-risk chemotherapy regimens administered to patients at 20% or…”
Get full text

Organizational systems used by California capitated medical groups and independent practice associations to increase cancer screening by Malin, Jennifer L., Kahn, Katherine, Dulai, Gareth, Farmer, Melissa M., Rideout, Jeffrey, Payne Simon, Lisa, Ganz, Patricia A.

“…BACKGROUND Patients in health maintenance organizations (HMOs) appear to have higher utilization of cancer screening tests than patients with fee‐for‐service…”
Get full text

Re: Personalized Medicine and Cancer Supportive Care: Appropriate Use of Colony-Stimulating Factor Support of Chemotherapy by Potosky, Arnold L., Malin, Jennifer L., Kim, Benjamin, Chrischilles, Elizabeth A., Weeks, Jane C.

Get full text

Predictors of febrile neutropenia among Medicare patients with breast, lung and colorectal cancer by Hosmer, W. D., Wong, M. D., Malin, J. L.

“…Abstract only 9120 Background: Neutropenia and associated impaired immunity is the major dose limiting toxicity for systemic chemotherapy administration…”
Get full text

Factors associated with chemotherapy receipt and intensity for stage IV colorectal cancer (CRC): A multihealth system, population-based study by Zafar, Y., Grambow, S. C., Abbott, D. H., Malin, J. L., Zullig, L. L., Kolimaga, J. T., Provenzale, D. T.

“…Abstract only 6519 Background: Little is known about chemotherapy practice patterns for patients with stage IV CRC. Methods: Cancer Outcomes Research &…”
Get full text

Results of the National Initiative for Cancer Care Quality: How Can We Improve the Quality of Cancer Care in the United States? by MALIN, Jennifer L, SCHNEIDER, Eric C, EPSTEIN, Arnold M, ADAMS, John, EMANUEL, Ezekiel J, KAHN, Katherine L

“…In 1999, the National Cancer Policy Board called attention to the quality of cancer care in the United States and recommended establishing a quality monitoring…”
Get full text

Use of colony stimulating factors (CSF) for primary prophylaxis of chemotherapy-induced neutropenia in community oncology practices to reduce risk of febrile neutropenia (FN) by Wong, M. D., Hershman, D., Morrison, V. A., Ding, B., Malin, J. L.

“…Abstract only 17013 Background: In addition to proof of efficacy from randomized controlled trials (RCTs), health care decision makers need data on therapy…”
Get full text

Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium by Ayanian, John Z, Chrischilles, Elizabeth A, Fletcher, Robert H, Fouad, Mona N, Harrington, David P, Kahn, Katherine L, Kiefe, Catarina I, Lipscomb, Joseph, Malin, Jennifer L, Potosky, Arnold L, Provenzale, Dawn T, Sandler, Robert S, van Ryn, Michelle, Wallace, Robert B, Weeks, Jane C, West, Dee W

Get full text

Developing a system to assess the quality of cancer care: ASCO's national initiative on cancer care quality by Schneider, Eric C, Malin, Jennifer L, Kahn, Katherine L, Emanuel, Ezekiel J, Epstein, Arnold M

Get full text

Cancer control-planning and monitoring population-based systems by Harford, Joe B, Edwards, Brenda K, Nandakumar, Ambakumar, Ndom, Paul, Capocaccia, Riccardo, Coleman, Michel P

“…Cancer is a growing global health issue, and many countries are ill-prepared to deal with their current cancer burden let alone the increased burden looming on…”
Get full text

Bridging the divide: integrating cancer-directed therapy and palliative care by Malin, Jennifer L

Get full text

Quality of Breast Cancer Care: What Do We Know? by Malin, Jennifer L, Schuster, Mark A, Kahn, Katherine A, Brook, Robert H

“…To critically review studies that describe patterns of care for breast cancer patients and to examine the data sources used for case identification and…”
Get full text

The cost-quality trade-off: need for data quality standards for studies that impact clinical practice and health policy by Malin, Jennifer L, Keating, Nancy L

Get full text

Developing a Reliable, Valid, and Feasible Plan for Quality-of-Care Measurement for Cancer: How Should We Measure? by Kahn, Katherine L., Malin, Jennifer L., Adams, John, Ganz, Patricia A.

“…Background. Recent changes in the US health care delivery system have raised expectations that the medical marketplace will compete on quality and cost of…”
Get full text

PCN7 PRIMARY PROPHYLAXIS AGAINST FEBRILE NEUTROPENIA WITH PEGFILGRASTIM IS COST-EFFECTIVE COMPARED WITH FILGRASTIM IN NON-HODGKIN'S LYMPHOMA PATIENTS RECEIVING CHOP-21 IN SPAIN by Lopez, A, Arocho, R, Atchison, C, Malin, JL, Liu, Z, Doan, QV, Dubois, RW

Get full text

PCN23 PRIMARY PROPHYLAXIS AGAINST FEBRILE NEUTROPENIA WITH PEGFILGRASTIM IS COST-EFFECTIVE COMPARED WITH FILGRASTIM IN NON-HODGKIN'S LYMPHOMA PATIENTS RECEIVING CHOP-21 IN ITALY by Chiroli, S, Ciceri, DF, Atchison, C, Malin, JL, Liu, Z, Doan, QV, Dubois, RW

Get full text

PCN9 PRIMARY PROPHYLAXIS OF FEBRILE NEUTROPENIA WITH PEGFILGRASTIM IS COST-EFFECTIVE COMPARED WITH SECONDARY PROPHYLAXIS FOR WOMEN WITH EARLYSTAGE BREAST CANCER RECEIVING CHEMOTHERAPY by Ramsey, SD, Liu, Z, Boer, R, Malin, JL, Sullivan, SD, Doan, QV, Dubois, RW, Lyman, GH

Get full text